Trump's trade deals could push the average new car price well above $50,000
But import taxes are still going up, and past experience tells us that American consumers will ultimately bear most of the cost. Some of the most important imports from Europe and Japan are cars and car parts, and the higher taxes are sure to make all facets of owning a car costlier, just as drivers were hoping for a break from soaring prices. Trump is still working on trade deals with Canada, Mexico, and South Korea, other major sources of auto imports, and those outcomes will likely hike prices further.
Switch Auto Insurance and Save Today!
Great Rates and Award-Winning Service
The Insurance Savings You Expect
Affordable Auto Insurance, Customized for You
The average new car costs nearly $49,000, according to Kelley Blue Book. Trump's tariffs could raise costs by $3,000 or more once fully priced in, with costs rising less for cheaper models and more for luxury makes. It could take several months for those import taxes to work through supply chains, but unless there's a recession that ravages demand, car prices seem certain to hit new record highs during Trump's second presidential term.
Read more: The latest news and updates on Trump's tariffs
Ten years ago, the average car price was just $30,000. Several factors have pushed prices higher. Americans increasingly buy big pickups and SUVs, which cost more. Manufacturers struggle to make money on small economy cars and have been pulling them from their lineups. An explosion of digital gizmos adds to the cost, as does new automaker investments in electrification, which still isn't profitable industrywide.
The COVID pandemic turbocharged auto inflation due to supply chain disruptions, parts shortages, stronger demand for non-urban transportation, and other factors. Costlier new cars increased demand for used cars, fueling inflation there, as well. More expensive parts and higher repair costs caused a surge in insurance premiums, which have doubled during the last 10 years. The charts below show the trends.
Auto inflation has stabilized — but prices aren't coming down. They're basically stuck at new, higher levels. The only real break for drivers has been gasoline prices, down about 10% during the last year, to a national average of about $3.15 per gallon.Automakers have been first-line victims of Trump's tariffs. That means their customers will feel the pain too. General Motors (GM) and Jeep-parent Stellantis (STLA) both said tariffs harmed profitability in the second quarter. Ford (F) will probably echo that theme when it reports earnings on July 30. Automakers aren't just suffering from tariffs on imported parts, but also from Trump's new 50% tariff on most imported steel and aluminum, which are major components in cars.
Most car prices haven't risen yet. The all-in cost of buying a car has actually dropped from peak levels of 2022, when the average cost of a new car equated to 42 weeks of work for the typical buyer, according to the Cox Automotive/Moody's Analytics affordability index, which accounts for prices, incomes, and interest rates. That's now down to about 37 weeks of work.
But overall costs are still about 10% higher in real terms than they were from 2012 through 2021. And it's only a matter of time before automakers start passing higher tariff costs onto buyers.
Some of the most popular cars in the US market are imports. The Subaru Impreza, Toyota (TM) Prius, and Mazda (7261.T) Miata come from Japan, as a few examples. Many Audis, BMWs (BMW.DE), and Mercedes (MBG.DE) come from Europe, along with the Volkswagen (VWAGY) Golf. Those imports will all come with the new 15% tax.
Korean imports include the Hyundai (005380.KS) Elantra, Kia Soul, and many other models from the two Korean manufacturers. They seem likely to face the same 15% import tax, since that is becoming the standard for Trump's trade deals.
Read more: What Trump's tariffs mean for the economy and your wallet
Mexico is the biggest source of automotive imports, supplying about 40% of all imported components, plus finished vehicles such as the Ford Maverick, Chevy Blazer, Mazda 3, and Nissan (NSANY) Sentra. Canada is another major source of vehicles such as the Chrysler Pacifica, Lexus RX 350, and many Honda (HMC) Civics. New Trump trade deals with Mexico and Canada seem further off, but in the meantime, he imposed a 25% tax on imported products from those countries that don't satisfy complex domestic-content requirements.
All told, about 46% of the 16 million cars sold in the United States each year are imports, and almost all of the cheapest economy cars on the market are imports because carmakers generally can't afford to make them in America.
Virtually all of those products will cost more because of the Trump tariffs. Earlier this year, when Trump was threatening 25% taxes on all imported cars, the Yale Budget Lab estimated such an across-the-board tariff would raise the cost of an average car by $6,400. That applied to all cars, whether imported or domestic, because price hikes in one major sector allow competitors to raise their prices too.
If the across-the-board tariff is 15% instead of 25%, price hikes would obviously be less. Manufacturers might make adjustments and 'eat' some of the cost by accepting lower profits. But they can't eat all of the additional cost. Shareholders won't accept it, and with costs rising throughout the industry, all automakers will have pricing power, allowing them to charge more.
Even if prices rise by less than under some other scenario, car buyers still have reason to expect lower prices from Trump, not higher ones. Trump ran for president last year, vowing to 'bring prices way down,' after three years of excessive inflation. Voters who went for Trump in 2024 said that was one of the main reasons they picked him. Yet earlier this year, Trump said he 'couldn't care less' if automakers raised prices to offset the cost of his tariffs.
They're going to. Maybe it won't be by as much as analysts thought before, but that won't comfort buyers facing sticker shock anew at the dealership, service center, auto parts store, and insurance agency. Those Trump trade deals won't look so rosy once people start to pay for them.
Rick Newman is a senior columnist for Yahoo Finance. Follow him on Bluesky and X: @rickjnewman.
Click here for political news related to business and money policies that will shape tomorrow's stock prices.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 minutes ago
- Yahoo
Microsoft (MSFT) Unveils AI-Powered ‘Copilot Mode' for Edge Browser
Microsoft Corporation (NASDAQ:MSFT) is one of the . On July 28, the company announced the launch of a new 'Copilot Mode' for its Edge browser. The Copilot Mode leverages artificial intelligence to improve the browsing experience for its users, helping carry out tasks, organize browsing, and even compare results across tabs without the need to switch between. According to Microsoft, the new feature will enable users to see a page with a single input box combining chat, search, and web navigation features. Moreover, Copilot will also support voice navigation for browsing in Edge. While not available at the moment, users will also be able to permit Copilot to access additional browser context, such as user history and credentials, to take more actions shortly. A hacker on his laptop. Photo by Sora Shimazaki on Pexels It will also be able to access browsing content when enabled, or even provide visual cues to allow users to know when it is active in the background. It will be available at no cost across Copilot markets in Windows and Mac PCs for a limited time. Microsoft Corporation (NASDAQ:MSFT) provides AI-powered cloud, productivity, and business solutions, focusing on efficiency, security, and AI advancements. While we acknowledge the potential of MSFT as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and Disclosure: None.
Yahoo
2 minutes ago
- Yahoo
Aspire Biopharma Holdings, Inc. Announces CEO Transition
Kraig Higginson, Current Chairman of the Board, Appointed Interim CEO ESTERO, FL / / July 30, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), developer of a multi-faceted patent-pending supplement delivery technology, today announced that the Company's Board of Directors (Board) has appointed Kraig Higginson as interim Chief Executive Officer (CEO), effective July 24, 2025. Mr. Higginson serves as Chairman of the Board and previously served as CEO of Aspire for four years. Michael C. Howe has resigned as CEO and as a member of the Board. The Board thanks Mr. Howe for his contributions to the Company and plans to initiate a search for a permanent CEO. "On behalf of the entire Board, I want to thank Michael for his contributions to the Company and wish him the very best in the future," said Kraig Higginson, Interim Chief Executive Officer of Aspire. "I look forward to leading Aspire with the same level of commitment as if I were in the role permanently, with a goal of continuing to execute on maximizing the potential of Aspire's powerful and differentiated drug delivery platform. We are fortunate to have a capable leadership team, and we will continue to focus on positioning the business for long-term success." The Company also announced the resignations of Mr. Gary E. Stein and Ms. Barbara Sher from the Board, effective immediately. The Aspire Board is very grateful for Mr. Steins's and Ms. Sher's outstanding service as members of the Board and for all of the thoughtful insights and valuable contributions they provided during their tenures. In connection with this transition, the Board of Directors appointed Howard Doss, to serve as Director and Chairman of the Audit Committee of the Company, effective immediately. Mr. Doss, age 71, has served as the Chief Financial Officer of PowerUp from August 2023 until February 2025. He is a seasoned chief financial officer and accountant. He served as Chief Financial Officer of Kernel Group Holdings, Inc. In 2021, he served as Chief Financial Officer of Aesther Healthcare Acquisition Corp., a special purpose acquisition company until it consummated its initial business combination in February 2023. He has also served as chief financial officer of Trade Health, Inc., an online marketplace for health traded on Nasdaq under the symbol "SCNX." Mr. Doss has served in a variety of capacities with accounting and investment firms. He joined the staff of Seidman & Seidman (BDO Seidman, Dallas) in 1977 and in 1980 he joined the investment firm Van Kampen Investments, opening the firm's southeast office in Tampa, Florida in 1982. He remained with the firm until 1996 when he joined Franklin Templeton. After working for the Principal Financial Group office in Tampa, Florida, Mr. Doss was City Executive for U.S. Trust in Sarasota, Florida, responsible for high-net-worth individuals. He retired from that position in 2009. He served as CFO and Director for Sansur Renewable Energy, an alternative energy development company, from 2010 to 2012. Mr. Doss has also served as President of Staradio Corp. since 2005. Mr. Doss is a member of the America Institute of CPA's. He is a graduate of Illinois Wesleyan University. About Aspire Biopharma, Inc. Headquartered in Estero, Fl., Aspire Biopharma has developed a disruptive technology that can deliver supplements and drugs rapidly and precisely. For more information, please visit Safe Harbor Statement Certain statements made in this communication are "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements may generally be identified by the use of words such as "estimate," "projects," "expects," "anticipates," "forecasts," "plans," "intends," "believes," "seeks," "may," "will," "would," "should," "future," "propose," "potential," "target," "goal," "objective," "outlook" and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements include, but are not limited to, statements regarding the financial position, business strategy and the plans and objectives of management for future operations. These statements are based on various assumptions, whether or not identified in this communication, and on the current expectations of Aspire's management and are not predictions of actual performance. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as and must not be relied on by any investor as a guarantee, an assurance, a prediction or a definitive statement of fact or probability. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside the control of the parties, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law. Aspire Biopharma Holdings, Inc. Contact PCG AdvisoryKevin McGrath+1-646-418-7002kevin@ SOURCE: Aspire Biopharma Holdings, Inc. View the original press release on ACCESS Newswire
Yahoo
2 minutes ago
- Yahoo
Homeowner with Farmers Insurance hit with 381% annual premium hike
A longtime customer of Farmers Insurance is facing a nearly 400% increase in her yearly homeowner's insurance premium.